Research into conolidine has triggered discovery of an opioid receptor in the body known as ACKR3/CXCR7. ACKR3 appears to be probably the most desired goal for conolidine, which also disregards the other four classical opioid receptors(3). Advancements from the understanding of the cellular and molecular mechanisms of pain as https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers